Literature DB >> 1319871

The effect of food on the bioavailability of temafloxacin. A review of 3 studies.

G R Granneman1, D Mukherjee.   

Abstract

Temafloxacin is a new fluoroquinolone antibacterial agent. Previous pharmacokinetic studies have shown that the extent of absorption of temafloxacin is independent of dose and that the dispositional pharmacokinetics are linear. The pharmacokinetics of 3 tablet formulations of temafloxacin were investigated in phase I studies in healthy adult volunteers, to determine whether the bioavailability is altered by the presence of food. Results of these studies indicate that the absorption of temafloxacin is slightly enhanced by concomitant administration of food. Thus, special coordination of temafloxacin administration and meals appears to be unnecessary.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319871     DOI: 10.2165/00003088-199200221-00009

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  13 in total

1.  The relative bioavailability of temafloxacin administered through a nasogastric tube with and without enteral feeding.

Authors:  T J Lubowski; C H Nightingale; K Sweeney; R Quintiliani
Journal:  Clin Pharmacokinet       Date:  1992       Impact factor: 6.447

2.  Pharmacokinetics of temafloxacin in humans after single oral doses.

Authors:  G R Granneman; P Carpentier; P J Morrison; A G Pernet
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

3.  Effect of food on absorption of lomefloxacin.

Authors:  W D Hooper; R G Dickinson; M J Eadie
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

4.  A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability.

Authors:  D J Schuirmann
Journal:  J Pharmacokinet Biopharm       Date:  1987-12

5.  Effect of food on enoxacin absorption.

Authors:  A A Somogyi; F Bochner; J A Keal; P E Rolan; M Smith
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

6.  The pharmacokinetics of ofloxacin in healthy adult male volunteers.

Authors:  A Leroy; F Borsa; G Humbert; P Bernadet; J P Fillastre
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Determining the probability of an important difference in bioavailability.

Authors:  B E Rodda; R L Davis
Journal:  Clin Pharmacol Ther       Date:  1980-08       Impact factor: 6.875

Review 8.  Pharmacokinetics of temafloxacin after multiple oral administration.

Authors:  G R Granneman
Journal:  Clin Pharmacokinet       Date:  1992       Impact factor: 6.447

9.  Hepatobiliary elimination of temafloxacin.

Authors:  F Sörgel; G R Granneman; G Mahr; P Kujath; W Fabian; P Nickel
Journal:  Clin Pharmacokinet       Date:  1992       Impact factor: 6.447

10.  Pharmacokinetics of temafloxacin in humans after multiple oral doses.

Authors:  G R Granneman; P Carpentier; P J Morrison; A G Pernet
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

View more
  5 in total

1.  Effect of antacid medication on the pharmacokinetics of temafloxacin.

Authors:  G R Granneman; U Stephan; B Birner; F Sörgel; D Mukherjee
Journal:  Clin Pharmacokinet       Date:  1992       Impact factor: 6.447

2.  Predicting effect of food on extent of drug absorption based on physicochemical properties.

Authors:  Chong-Hui Gu; Hua Li; Jaquan Levons; Kimberley Lentz; Rajesh B Gandhi; Krishnaswamy Raghavan; Ronald L Smith
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.200

3.  Effects of milk and food on the absorption of enoxacin.

Authors:  P Lehto; K T Kivistö
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335

Review 4.  Effects of food on clinical pharmacokinetics.

Authors:  B N Singh
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

Review 5.  Absorption interactions with fluoroquinolones. 1995 update.

Authors:  B M Lomaestro; G R Bailie
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.